🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Patients with salivary gland carcinoma were divided into groups according t...
Status
Recruiting
Location
Fei Ma
Start Date
2023-08-15
Trial ID
NCT06145308
Treatments Being Tested
This study is a prospective, single-center, open-label, umbrella-shaped pha...
Status
Unknown
Location
Cancer Hospital Affiliated to Fudan University
Start Date
2020-05-01
Trial ID
NCT04355858
Capecitabine combined with pyrotinib is the standard protocol for HR+/HER2+...
Status
Recruiting
Location
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Start Date
2020-10-14
Trial ID
NCT04646759
Treatments Being Tested
This study is a prospective, single-arm, phase II clinical study for patien...
Status
Unknown
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Start Date
2022-11-01
Trial ID
NCT05577923
Treatments Being Tested
This is a phase II trial exploring the maintenance therapy with trastuzumab...
Status
Not Yet Recruiting
Location
Fudan University
Start Date
2025-09-10
Trial ID
NCT07179939
This is an open-label, single-center, exploratory, Phase Ib/II clinical tri...
Status
Recruiting
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2025-06-23
Trial ID
NCT07708194
Treatments Being Tested
Efficacy and Safety of Dalpiciclib Combined with Anti-HER2 Targeted Therapy...
Status
Recruiting
Location
Sun yat-Sen University Cancer Center, Guangzhou, Yuexiu District
Start Date
2026-06-01
Trial ID
NCT07610720
Treatments Being Tested
HR+/HER2+（Human epidermal growth factor receptor 2 positive and hormone rec...
Status
Unknown
Location
Sun Yat-Sen University Cancer Center
Start Date
2019-07-17
Trial ID
NCT04034589
Treatments Being Tested
This is a prospective Single-arm Study to Investigate the Efficacy and Safe...
Status
Unknown
Location
Fudan University Shanghai Cancer Hospital
Start Date
2021-10-15
Trial ID
NCT05076695
Treatments Being Tested
This study is an open-label, multicenter, Phase Ib/II clinical study to eva...
Status
Recruiting
Location
Henan Provincial Cancer Hospital
Start Date
2024-01-11
Trial ID
NCT06208410